Cipla receives EIR for its Indore facility
From USFDA
Cipla has received Establishment Inspection Report (EIR) from the US FDA for its Indore facility indicating formal closure of the US FDA inspection conducted in July/August, 2015.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content